Efficacy of Changing to DUOTRAV® From Prior Therapy
Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to assess the efficacy and tolerability of changing to DUOTRAV®
from prior bimatoprost 0.03%/timolol 0.5% pharmacotherapy in subjects with open-angle
glaucoma or ocular hypertension having uncontrolled intraocular pressure (IOP).